ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase"

被引:17
|
作者
Lu, Ying [2 ]
Zhao, Xiaohui [3 ]
Wang, Endi [4 ]
Chen, Wei [5 ]
Huang, Qin [1 ]
机构
[1] City Hope Natl Med Ctr, Div Pathol, Dept Pathol, Duarte, CA 91010 USA
[2] Ningbo 1 Hosp, Dept Hematol, Ningbo, Zhejiang, Peoples R China
[3] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA
[4] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
[5] Zhejiang Univ, Coll Med, Sir Run Run Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
Anaplastic large cell lymphoma; Leukemic phase; Bone marrow and blood; POLYMERASE CHAIN-REACTION; OF-THE-LITERATURE; NON-HODGKINS-LYMPHOMA; T-CELL; CLINICOPATHOLOGICAL ENTITY; MALIGNANT HISTIOCYTOSIS; KI-1; LYMPHOMA; VARIANT TYPE; KINASE GENE; TRANSLOCATION;
D O I
10.1016/j.leukres.2009.07.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CD30-positive anaplastic large cell lymphoma (ALCL) is a distinctive malignant large cell lymphoma of T-cell lineage, often presenting in lymph node or extranodal sites. ALCL cases with extensive bone marrow and peripheral blood involvement manifested as "leukemic phase" are extremely rare and the most of those cases reported are anaplastic large cell lymphoma kinase (ALK) positive ALCL in childhood population. Here we report four adult cases of ALK-negative ALCL with extensive bone marrow and peripheral blood involvement manifested as "leukemic phase". Circulating large lymphoma cells varied from 20 to 80% in peripheral blood and bone marrow biopsy showed various nodular or interstitial infiltrates. By reviewing the clinicopathologic data of previously reported ALCL cases with extensive bone marrow and peripheral blood involvement, there appears to be of large variations in regard to the patient's age, morphologic variants, immunophenotypic or genotypic characteristics of the disease. While most cases of ALCL with peripheral blood and bone marrow involvement were ALK-positive or carrying t(2; 5) translocation, rare ALK-negative cases were also present. Leukemic ALCL patients usually have unfavourable prognosis, regardless of ALK expression. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 50 条
  • [31] Leukemic phase of ALK-positive anaplastic large cell lymphoma
    He, Rong
    Viswanatha, David S.
    BLOOD, 2013, 121 (11) : 1934 - 1934
  • [32] ALK-negative anaplastic large cell lymphoma masquerading as allergic contact dermatitis of the face
    Thomas, L.
    Cousen, P.
    Svec, A.
    Robinson, K.
    Carmichael, A. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (04) : E122 - E122
  • [33] Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
    G Hu
    S Dasari
    Y W Asmann
    P T Greipp
    R A Knudson
    H K Benson
    Y Li
    B W Eckloff
    J Jen
    B K Link
    L Jiang
    J S Sidhu
    L E Wellik
    T E Witzig
    N N Bennani
    J R Cerhan
    R L Boddicker
    A L Feldman
    Leukemia, 2018, 32 : 565 - 569
  • [34] ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature
    Lannon, Melissa
    Lu, Jian-Qiang
    Chum, Marvin
    Wang, Bill Hao
    BRITISH JOURNAL OF NEUROSURGERY, 2023, 37 (05) : 1245 - 1250
  • [35] ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified
    ten Berge, RL
    de Bruin, PC
    Oudejans, JJ
    Ossenkoppele, GJ
    van der Valk, P
    Meijer, CJLM
    HISTOPATHOLOGY, 2003, 43 (05) : 462 - 469
  • [36] Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
    Ahmed, Reham
    Feldman, Andrew L.
    BLOOD, 2024, 143 (10) : 938 - 938
  • [37] Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
    Hu, G.
    Dasari, S.
    Asmann, Y. W.
    Greipp, P. T.
    Knudson, R. A.
    Benson, H. K.
    Li, Y.
    Eckloff, B. W.
    Jen, J.
    Link, B. K.
    Jiang, L.
    Sidhu, J. S.
    Wellik, L. E.
    Witzig, T. E.
    Bennani, N. N.
    Cerhan, J. R.
    Boddicker, R. L.
    Feldman, A. L.
    LEUKEMIA, 2018, 32 (02) : 565 - 569
  • [38] BRENTUXIMAB VEDOTIN FOR T-CELL LYMPHOMA: A CASE OF ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
    Sumbly, V.
    Landry, I.
    Rizzo, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (04) : 1155 - 1155
  • [39] Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase
    Anderson, Jessica
    Putnam, Eileen
    Liu, Wei
    Menon, Madhu P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (01) : 67 - 68
  • [40] ALK Positive Anaplastic Large Cell Lymphoma Presenting as Extensive Bone Involvement
    Gajendra, Smeeta
    Sachdev, Ritesh
    Lipi, Lipika
    Goel, Shalini
    Misra, Ruchira
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (01) : XD4 - XD5